The equity markets have collapsed in 2025, the IPO window is closed, the FDA is in turmoil, the NIH is being gutted… and it’s a great time to start new biotech companies. Why? Because there are so few being created The post Biotech Venture Creation: The Benefits Of Scarcity appeared first on LifeSciVC.
